Theralase Technologies Inc
XTSX:TLT

Watchlist Manager
Theralase Technologies Inc Logo
Theralase Technologies Inc
XTSX:TLT
Watchlist
Price: 0.19 CAD 2.7%
Market Cap: 47.1m CAD
Section:
Relative Value
Relative Value
Valuation Multiples
Multiples Across Competitors
See Also

Relative Value

The Relative Value of one TLT stock under the Base Case scenario is 0.27 CAD. Compared to the current market price of 0.19 CAD, Theralase Technologies Inc is Undervalued by 28%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

TLT Relative Value
Base Case
0.27 CAD
Undervaluation 28%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

45.6
P/S
P/S
Price to Sales
45.6
vs History
63
vs Industry
4
Median 3Y
54.6
Median 5Y
50.6
Industry
2.2
Forward
50.2
More Details
Negative
P/E
P/E
Price to Earnings
N/A
vs History
vs Industry
Median 3Y
-11
Median 5Y
-10.7
Industry
21.8
Forward
-9.2
More Details
Negative
P/OCF
P/OCF
Price to OCF
N/A
vs History
vs Industry
Median 3Y
-12.9
Median 5Y
-12.5
Industry
13.5
More Details
Negative
P/FCFE
P/FCFE
Price to FCFE
N/A
vs History
vs Industry
Median 3Y
-12.5
Median 5Y
-12
Industry
19.8
More Details
22.8
P/B
P/B
Price to Book Value
22.8
vs History
38
vs Industry
2
Median 3Y
25.3
Median 5Y
19.7
Industry
2.1
More Details
45.5
EV/S
EV/S
Enterprise Value to Sales
45.5
vs History
52
vs Industry
4
Median 3Y
52.5
Median 5Y
47.1
Industry
2.3
Forward
50.1
More Details
84.8
EV/GP
EV/GP
Enterprise Value to Gross Profit
84.8
vs History
80
vs Industry
3
Median 3Y
105.7
Median 5Y
115.7
Industry
4.8
More Details
Negative
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
N/A
vs History
vs Industry
Median 3Y
-11.7
Median 5Y
-11.1
Industry
11.5
More Details
Negative
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
N/A
vs History
vs Industry
Median 3Y
-11
Median 5Y
-10.4
Industry
15.7
More Details
Negative
EV/OCF
EV/OCF
Enterprise Value to OCF
N/A
vs History
vs Industry
Median 3Y
-12.8
Median 5Y
-12
Industry
13.5
More Details
Negative
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
N/A
vs History
vs Industry
Median 3Y
-12.6
Median 5Y
-11.6
Industry
17.6
More Details
18
EV/IC
EV/IC
Enterprise Value to IC
18
vs History
74
vs Industry
4
Median 3Y
25.1
Median 5Y
24
Industry
1.8
More Details

Multiples Across Competitors

TLT Competitors Multiples
Theralase Technologies Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
Market Cap P/S P/E EV/EBITDA EV/EBIT
CA
Theralase Technologies Inc
XTSX:TLT
47.1m CAD 45.6 -11.1 -11.7 -11
US
Abbott Laboratories
NYSE:ABT
229.7B USD 5.4 17 22.1 31.7
US
Intuitive Surgical Inc
NASDAQ:ISRG
198.7B USD 22.8 80.3 64.2 77.3
US
Boston Scientific Corp
NYSE:BSX
152B USD 8.7 74.7 35.3 49.1
US
Stryker Corp
NYSE:SYK
148.6B USD 6.4 52 25.7 30.9
IE
Medtronic PLC
NYSE:MDT
110B USD 3.3 25.8 13.8 19.5
DE
Siemens Healthineers AG
XETRA:SHL
54.5B EUR 2.4 26.1 14.6 20.2
US
Becton Dickinson and Co
NYSE:BDX
49.7B USD 2.4 32.7 13.1 24.5
US
Edwards Lifesciences Corp
NYSE:EW
43.7B USD 7.9 10.5 23.9 26.3
US
IDEXX Laboratories Inc
NASDAQ:IDXX
41B USD 10.4 45.8 32.5 36.3
CN
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
277.8B CNY 7.8 24.9 21.8 21.8

See Also

Summary
TLT intrinsic value, competitors valuation, and company profile.
DCF Valuation
TLT stock valuation using Discount Cash Flow valuation method.
Relative Valuation
TLT stock valuation using valuation multiples.
Wall Street Estimates
TLT price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
TLT stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 254,100+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.